IRIDEX Corp.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.70
- 52-Week Range
- $0.47 – $1.65
- Market Cap
- $8.90M
- P/E (TTM)
- —
- EPS (TTM)
- -0.19
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- 0.94
- Return on Equity
- -92.36%
- Return on Assets
- -5.49%
- Gross Margin
- 38.21%
- Operating Margin
- -5.14%
- Profit Margin
- -6.85%
- Current Ratio
- 1.76
- Debt/Equity
- 2.83
- Total Debt
- $7.43M
- Free Cash Flow
- —
- Revenue Growth
- -18.60%
- Earnings Growth
- —
- Enterprise Value
- $18.56M
Market Snapshot
About
IRIDEX Corporation is a medical technology company that designs, develops, and manufactures ophthalmology laser systems and delivery devices. The company's products are used to treat a range of eye diseases including diabetic retinopathy, glaucoma, and retinal tears. IRIDEX's portfolio includes semiconductor-based laser consoles, delivery devices, and consumables used by ophthalmologists in clinical and surgical settings. The company focuses on developing innovative laser-based treatments that provide effective, minimally invasive therapeutic options for retinal and glaucoma patients worldwide.